1. Home
  2. RFL vs SACH Comparison

RFL vs SACH Comparison

Compare RFL & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.55

Market Cap

54.4M

Sector

Finance

ML Signal

HOLD

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

HOLD

Current Price

$1.13

Market Cap

52.0M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
RFL
SACH
Founded
2017
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Real Estate Investment Trusts
Sector
Finance
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
54.4M
52.0M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
RFL
SACH
Price
$1.55
$1.13
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$2.00
AVG Volume (30 Days)
122.1K
184.7K
Earning Date
11-19-2025
11-05-2025
Dividend Yield
N/A
17.70%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$917,000.00
$3,906,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.73
P/E Ratio
N/A
N/A
Revenue Growth
43.96
N/A
52 Week Low
$1.17
$0.80
52 Week High
$3.19
$1.48

Technical Indicators

Market Signals
Indicator
RFL
SACH
Relative Strength Index (RSI) 76.97 63.85
Support Level $1.21 $1.00
Resistance Level $1.29 $1.14
Average True Range (ATR) 0.08 0.05
MACD 0.03 0.02
Stochastic Oscillator 95.00 85.00

Price Performance

Historical Comparison
RFL
SACH

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

Share on Social Networks: